BioAmber (BIOA) Tops Q1 EPS by 13c

BioAmber (NYSE: BIOA) reported Q1 EPS of $0.00, $0.13 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $2.12 million versus the consensus estimate of $4.02 million.

For earnings history and earnings-related data on BioAmber (BIOA) click here.

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• Acrivon Therapeutics, Inc. (ACRV) Tops Q2 EPS by 21c
• Capstone Energy+, Inc. (CEPL) Reports Q2 Loss of $0.03